Money Matters: Out-Of-Pocket Expenses Impact Treatment Adherence For Cancer Patients
Monday, January 6, 2014 - 20:50
in Health & Medicine
No one wants to work for free; doctors have to pay for insurance and employees and their medical school loans, drug companies spend billions on each drug and 95 percent of the time the drugs will never make it to market. And that chain of money flows to cancer patients as well. Cutting-edge pharmaceuticals are expensive and for poorer people, unless they get a cost waiver from the company, even the co-payment for insurance may be too much. It's no surprise that when the patient's share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina. read more